News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
712,638 Results
Type
Article (40458)
Company Profile (264)
Press Release (671908)
Multimedia
Podcasts (71)
Webinars (17)
Section
Business (204484)
Career Advice (2017)
Deals (35483)
Drug Delivery (99)
Drug Development (81251)
Employer Resources (173)
FDA (16316)
Job Trends (14919)
News (345953)
Policy (32688)
Tag
Academia (2558)
Accelerated approval (15)
Adcomms (24)
Allergies (114)
Alliances (49573)
ALS (133)
Alzheimer's disease (1552)
Antibody-drug conjugate (ADC) (216)
Approvals (16412)
Artificial intelligence (391)
Autoimmune disease (66)
Automation (27)
Bankruptcy (361)
Best Places to Work (11636)
BIOSECURE Act (20)
Biosimilars (148)
Biotechnology (175)
Bladder cancer (128)
Brain cancer (45)
Breast cancer (483)
Cancer (3748)
Cardiovascular disease (297)
Career advice (1697)
Career pathing (33)
CAR-T (221)
CDC (42)
Cell therapy (594)
Cervical cancer (31)
Clinical research (68088)
Collaboration (1283)
Company closure (4)
Compensation (910)
Complete response letters (43)
COVID-19 (2677)
CRISPR (70)
C-suite (550)
Cystic fibrosis (128)
Data (4461)
Decentralized trials (2)
Denatured (22)
Depression (93)
Diabetes (416)
Diagnostics (6531)
Digital health (33)
Diversity (10)
Diversity, equity & inclusion (45)
Drug discovery (182)
Drug pricing (154)
Drug shortages (28)
Duchenne muscular dystrophy (191)
Earnings (88760)
Editorial (45)
Employer branding (21)
Employer resources (151)
Events (115261)
Executive appointments (922)
FDA (18705)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (6)
Frontotemporal dementia (14)
Funding (1168)
Gene editing (155)
Generative AI (30)
Gene therapy (471)
GLP-1 (861)
Government (4598)
Grass and pollen (5)
Guidances (347)
Healthcare (18855)
HIV (42)
Huntington's disease (34)
IgA nephropathy (59)
Immunology and inflammation (201)
Immuno-oncology (16)
Indications (52)
Infectious disease (2897)
Inflammatory bowel disease (170)
Inflation Reduction Act (13)
Influenza (91)
Intellectual property (184)
Interviews (315)
IPO (16608)
IRA (48)
Job creations (3639)
Job search strategy (1426)
Kidney cancer (15)
Labor market (72)
Layoffs (532)
Leadership (27)
Legal (7937)
Liver cancer (85)
Longevity (11)
Lung cancer (540)
Lymphoma (259)
Machine learning (29)
Management (59)
Manufacturing (572)
MASH (130)
Medical device (13607)
Medtech (13630)
Mergers & acquisitions (19740)
Metabolic disorders (1022)
Multiple sclerosis (131)
NASH (16)
Neurodegenerative disease (195)
Neuropsychiatric disorders (48)
Neuroscience (2493)
NextGen: Class of 2025 (6516)
Non-profit (4493)
Now hiring (58)
Obesity (480)
Opinion (238)
Ovarian cancer (132)
Pain (149)
Pancreatic cancer (165)
Parkinson's disease (225)
Partnered (27)
Patents (399)
Patient recruitment (309)
Peanut (52)
People (58209)
Pharmaceutical (63)
Pharmacy benefit managers (23)
Phase I (21194)
Phase II (29980)
Phase III (22335)
Pipeline (2665)
Policy (242)
Postmarket research (2564)
Preclinical (9018)
Press Release (64)
Prostate cancer (189)
Psychedelics (42)
Radiopharmaceuticals (256)
Rare diseases (590)
Real estate (5936)
Recruiting (69)
Regulatory (23442)
Reports (51)
Research institute (2350)
Resumes & cover letters (351)
Rett syndrome (15)
RNA editing (11)
RSV (66)
Schizophrenia (123)
Series A (191)
Series B (147)
Service/supplier (11)
Sickle cell disease (74)
Special edition (20)
Spinal muscular atrophy (149)
Sponsored (34)
Startups (3600)
State (2)
Stomach cancer (14)
Supply chain (92)
Tariffs (79)
The Weekly (47)
Vaccines (901)
Venture capital (63)
Weight loss (309)
Women's health (54)
Worklife (17)
Date
Last 7 days (682)
Last 30 days (2274)
Last 365 days (30420)
2025 (24501)
2024 (35218)
2023 (40076)
2022 (51174)
2021 (55710)
2020 (54083)
2019 (46540)
2018 (35020)
2017 (32111)
2016 (31480)
2015 (37552)
2014 (31321)
2013 (26345)
2012 (28571)
2011 (29263)
2010 (27328)
Location
Africa (726)
Alabama (71)
Alaska (7)
Arizona (267)
Arkansas (13)
Asia (38648)
Australia (6330)
California (9145)
Canada (2814)
China (836)
Colorado (384)
Connecticut (392)
Delaware (254)
Europe (83218)
Florida (1365)
Georgia (296)
Hawaii (2)
Idaho (60)
Illinois (708)
India (45)
Indiana (436)
Iowa (18)
Japan (314)
Kansas (118)
Kentucky (33)
Louisiana (17)
Maine (68)
Maryland (1201)
Massachusetts (6678)
Michigan (280)
Minnesota (527)
Mississippi (4)
Missouri (109)
Montana (29)
Nebraska (25)
Nevada (103)
New Hampshire (71)
New Jersey (2515)
New Mexico (28)
New York (2485)
North Carolina (1246)
North Dakota (8)
Northern California (4239)
Ohio (278)
Oklahoma (20)
Oregon (36)
Pennsylvania (1925)
Puerto Rico (18)
Rhode Island (43)
South America (1099)
South Carolina (48)
South Dakota (1)
Southern California (3518)
Tennessee (146)
Texas (1412)
United States (33164)
Utah (270)
Virginia (219)
Washington D.C. (77)
Washington State (763)
West Virginia (4)
Wisconsin (78)
Wyoming (1)
712,638 Results for "progenity inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Rani Therapeutics Announces Partnership with ProGen on Development of Oral Obesity Treatment
Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”)(Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs, today announced that it has entered into a definitive agreement with ProGen Co., Ltd.
June 24, 2024
·
7 min read
Press Releases
Rani Therapeutics and ProGen Announce Late Breaking Presentation at ENDO 2025 Demonstrating Bioequivalence of Novel, Bispecific GLP-1/GLP-2 Receptor Agonist Delivered Orally via RaniPill Compared to Subcutaneous Delivery
July 14, 2025
·
1 min read
Press Releases
Rentschler Biopharma Inc. named Manufacturer of the Year for Central Massachusetts
October 24, 2025
·
4 min read
Press Releases
Apollomics, Inc. Company Operational Continuity Update
October 14, 2025
·
6 min read
Press Releases
Inotiv, Inc. to Participate in Three Investor Conferences in November 2025
October 21, 2025
·
4 min read
Press Releases
Medpace Holdings, Inc. Reports Third Quarter 2025 Results
October 22, 2025
·
18 min read
Press Releases
PreveCeutical Provides Update on Plan of Arrangement with BioGene Therapeutics Inc.
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES
October 20, 2025
·
5 min read
Press Releases
Boston Scientific Announces Agreement to Acquire Nalu Medical, Inc.
October 20, 2025
·
8 min read
Press Releases
GRAIL, Inc. Announces $325.0 Million Private Placement Financing
October 21, 2025
·
5 min read
Press Releases
Progyny, Inc. Announces Details for Its Third Quarter 2025 Results Report
October 24, 2025
·
1 min read
1 of 71,264
Next
